Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,612.00
Bid: 1,613.00
Ask: 1,614.00
Change: 12.00 (0.75%)
Spread: 1.00 (0.062%)
Open: 1,608.00
High: 1,619.00
Low: 1,604.50
Prev. Close: 1,600.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Conn's, Lorillard, GW Pharma, DryShips

Tue, 31st Mar 2015 13:25

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock were poised to open lower on Tuesday, indicating amodest retreat from the previous session's rally, though the S&P500 remained on track for its ninth straight quarterly rise. DowJones industrial average futures were down 0.49 percentat 17,772, S&P 500 futures were down 0.47 percent at2,065.75 and Nasdaq 100 futures were down 0.33 percent at4,358.

** CONN'S INC, Monday close $28.67, -2.34 pctpremarket

The electronics rent-to-own retailer reportedbetter-than-expected fourth-quarter revenue and said it isactively pursuing the sale of all or part of its loan portfolioor other refinancing of its loan portfolio. The company is alsodiscontinuing sales of video games, digital cameras and certaintablets from year started February, due to higher charge-offrates and lower product margins.

** GW PHARMA PLC, Monday close $88.4, +3.47 pctpremarket

The British maker of cannabis-based drugs said ithas started the second leg of a mid-stage trial testingEpidiolex to treat Dravet syndrome, a rare, treatment-resistantform of childhood epilepsyelectronics. Data from the trial isexpected at end of year and GW expects to submit a marketingapplication to the FDA in mid-2016. Epidiolex will also undergolate-stage testing to treat Lennox-Gastaut syndrome.

** DRYSHIPS INC, Monday close $0.81, +3.70 pctpremarket

The drybulk shipper agreed to sell its four Suezmax tankersfor about $245 million through its majority owned subsidiaryOcean Rig UDW Inc. The company also said it has entered into anagreement to potentially sell its six Aframax tankers for about$291 million.

** J C PENNEY CO INC, Monday close $7.83, +2.94 pctpremarket

Analysts at Piper Jaffray raised their price target on thedepartment store chain's stock to $14, according to SeekingAlpha. The brokerage also raised its estimates for the companybased on inventory channel checks, Seeking Alpha reported.

** PRICELINE GROUP INC, Monday close$1,149.83, +1.21 pct premarket

Analysts at Stifel Nicolaus raised their rating on thetravel website operator to "buy" from "hold", saying thestabilizing European economy should help the company.

** SYNTA PHARMACEUTICALS CORP, Monday close$2.33, -20.60 pct premarket

The drug developer said it would commence a public offeringof common shares, but did not say when the offering would becompleted or provide any details on the number of shares orprice.

** REYNOLDS AMERICAN INC, Monday close $69.47, -3.48pct premarket

** LORILLARD INC, Monday close $66.42, -2.44 pctpremarket

The Federal Trade Commission staff is recommending a suit toblock the $27 billion merger of the second- and third-biggestcigarette makers, Reynolds American and Lorillard, the New YorkPost reported, citing a well-placed DC source not working on thecase said. (http://bit.ly/1xuMHLZ)

** VAALCO ENERGY INC, Monday close $3.13, -14.70 pctpremarket

The oil and gas producer said it is abandoning its firstwell drilled offshore Angola as it was found to bewater-bearing.

** INSMED INC, Monday close $21.09, -3.51 pctpremarket

The drug developer said it is offering 10 million shares ofits common stock, and intends to use the proceeds to developrespiratory drugs ARIKAYCE and INS1009.

** TECK RESOURCES LTD, Monday close $15.27, -7.92pct premarket

The Canadian miner and Antofagasta Plc denied that they were in talks about a merger after Bloombergreported that the two mining companies were in early stagetalks. Teck said in a statement that it was not in discussionswith Antofagasta "in relation to any form of transaction."

** GLAXOSMITHKLINE PLC, Monday close $47.2, -2.50pct premarket

** JOHNSON & JOHNSON, Monday close $101.55, -0.40pct premarket

GlaxoSmithKline has agreed to settle a lawsuit byJohnson & Johnson accusing it of using false advertising at thestart of the U.S. allergy season to grab market share.

** GROUPON INC, Monday close $7.43, -0.67 pctpremarket

** KKR & CO LP, Monday close $22.77

Private equity firms KKR and Hong Kong-based Anchor Partnersare in talks to buy a majority stake in Groupon's South Koreanunit for around 350 billion won ($316 million), a South Koreannewspaper reported on Tuesday.

($1 = 1,107.3200 won)

** CBRE GROUP INC, Monday close $36.41, +1.62 pctpremarket

** JOHNSON CONTROLS INC, Monday close $49.83, +0.92pct premarket

Johnson Controls, the largest U.S. auto parts maker, said itwould sell its business that helps corporations manage theirreal estate energy needs to real estate services firm CBRE Groupfor $1.48 billion in cash. CBRE, the world's largest commercialreal estate services firm, said it expects the deal to add toadjusted earnings in 2016.

** ENDURANCE SPECIALTY HOLDINGS LTD, Monday close$64.3

** MONTPELIER RE HOLDINGS LTD, Monday close$38.15, +3.54 pct premarket

Property and casualty insurer Endurance Specialty will buyreinsurer Montpelier Re for about $1.83 billion in cash andstock, to boost its Lloyd's of London underwriting business.Montpelier shareholders will get 0.472 Endurance share and $9.89in cash for each share held, the companies said on Tuesday. Thisrepresents $40.24 per share for Montpelier, a 5.5 percentpremium to the stock's closing on Monday.

** BIOCRYST PHARMACEUTICALS INC, Monday close$8.57, +6.18 pct premarket

The drug developer said it won a U.S. government contractfor the continued development of its potential treatment forviral diseases, including Ebola. The 18-month contract includesa base value of $12.1 million to support manufacturing, as wellas $22.9 million in additional development options that can beexercised by the government.

** CHARTER COMMUNICATIONS INC, Monday close$183.39, +6.87 pct premarket

Cable television operator Charter Communications Inc said it would buy Bright House Networks in acash-and-stock deal valued at $10.4 billion to expand inFlorida. Bright House, controlled by the Newhouse family, hasabout 2 million video customers in central Florida, includingOrlando and Tampa Bay as well as Alabama, Indiana, Michigan, andCalifornia.

** MOSAIC CO, Monday close $47.36, +0.13 pctpremarket

The U.S. fertilizer company said it would raise its annualdividend by 10 cents to $1.10 per share, effective in May. Themove comes despite recent tax changes by the Canadian provinceof Saskatchewan, where Mosaic mines the crop nutrient potash,which the company said earlier would cost it $80 million to $100million in 2015.

** QUEST DIAGNOSTICS INC, Monday close $77.69, -2.68pct premarket

** QUINTILES TRANSNATIONAL HOLDINGS INC, Monday close$68

Medical test maker Quest Diagnostics and contract researchcompany Quintiles Transnational said they were combining theirclinical trial laboratory operations in a joint venture, ofwhich Quintiles will own 60 percent.

** CABLEVISION SYSTEMS CORP, Monday close$18.48, +0.92 pct premarket

The U.S. cable T.V. operator is planning to make an offerfor the New York Daily News as early as this week, valuing thetroubled tabloid at just $1, according to a person familiar withthe matter.

** INTERNATIONAL BUSINESS MACHINES CORP, Mondayclose $162.67, -0.66 pct premarket

The company said it would invest $3 billion over the nextfour years in a new 'Internet of Things' unit, aiming to sellits expertise in gathering and making sense of the surge inreal-time data.

** CITIGROUP INC, Monday close $51.64, -0.62 pctpremarket

The U.S. bank has agreed to sell its credit card unit inJapan to Sumitomo Mitsui Trust Bank, the companies said onTuesday, as Citi slims down globally to bolster itsprofitability.

** CONOCOPHILLIPS, Monday close $64, -0.98 pctpremarket

The American oil company plans to invest about $2.5 billionin Indonesia's upstream oil and gas industry over the next threeor four years, the nation's energy minister said on Tuesday.

** ALIBABA GROUP HOLDING LTD, Monday close$83.9, -0.32 pct premarket

The online retailer's healthcare subsidiary will tie-up withZhejiang DiAn Diagnostics Co Ltd to help develop anonline hospital platform, the diagnostics firm said in a filinglate on Monday.

** EXXON MOBIL CORP, Monday close $85.63, -0.74 pctpremarket

The oil and gas producer said it started production in thedeepwater Gulf of Mexico at Hadrian South, its deepest subseatie-back. The daily gross production from the project isexpected to reach about 300 mln cubic feet of gas and 3,000barrels of liquids from two wells.

** COMCAST CORP, Monday close $56.61, -0.04 pctpremarket

The largest U.S. cable operator said it would form a newcompany with its chief financial officer, Michael Angelakis, toinvest in and focus on operating growth-oriented companies bothin the United States and international markets. The new companywould have total capital commitments of up to $4.1 billion, ofwhich $4 billion will be invested by Comcast. At least $40million will be invested by Angelakis.

** SPRINT CORP, Monday close $4.75

Sprint has agreed to settle a $131 million lawsuit accusingit of defrauding shareholders by issuing false and misleadingstatements about its tightened credit standards, improvements inits subscriber base, and the success of its merger with NextelCommunications Inc. (Compiled by Ramkumar Iyer in Bengaluru; Editing by SimonJennings)

More News
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.